Clinical Trials Directory

Trials / Unknown

UnknownNCT01685905

The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection

Evaluation of the Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Mycobacterium Tuberculosis Infection in Korean Patients With Rheumatic Diseases

Status
Unknown
Phase
Study type
Observational
Enrollment
2,000 (estimated)
Sponsor
Hanyang University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The purposes of this study 1. to compare the positivity of tuberculin skin test(TST) and QuantiFERON-TB Gold (QFT-G), and determine the level of agreement between two tests in patients with rheumatic diseases 2. to evaluate the difference in the occurrence of active TB in patients who receive both QFT-G and TST compared with those who receive only TST for detecting of Latent tuberculosis infection(LTBI) who are candidates of TNF inhibitors.

Detailed description

Study Assessment 1. The positive rates of QFT-G and TST as a screening test for LTBI * The positive rates of QFT-G and TST will be analyzed * Additional analysis will be performed according to the type of disease 2. The agreement between QFT-G and TST as a screening test for LTBI * The agreement between QFT-G and TST will be analyzed for patients with rheumatic diseases who examined both QFT-G and TST * Additional analysis will be performed according to the type of disease 3. The correlation of the occurrence of active TB and two tests (QFT-G and TST) * The analysis of the correlation of the occurrence of active TB and two tests will be conducted for patients who have experienced anti-TNF agents 3-1. The occurrence of active TB in accordance with results of TST 3-2. The occurrence of active TB in accordance with results of QFT-G 3-3. The difference in the occurrence of active TB in patients performed both QFT-G and TST compared with those performed only TST for detecting of LTBI who are candidates of TNF inhibitors (pilot study).

Conditions

Timeline

Start date
2012-04-01
Primary completion
2013-09-01
Completion
2013-09-01
First posted
2012-09-14
Last updated
2012-09-18

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT01685905. Inclusion in this directory is not an endorsement.